Prospective descriptive study of the infectious aetiology of otitis media and of nasopharyngeal bacterial flora of children in New Zealand under two different pneumococcal vaccination schedules. Multicentre Trial of under 3 year old children at Starship, Counties Manukau and Canterbury DHB's.
Phase of Trial: Phase IV
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Therapeutic Use
- Acronyms OMIVI
- Sponsors GlaxoSmithKline
- 08 Jun 2016 Status changed from not yet recruiting to completed.
- 27 Apr 2011 New trial record